Head: Dr. med. Timon Hansen

The myeloma and amyloidosis consultation session is led by Dr. med. Timon Hansen, who has been involved with research and treatment of multiple myeloma for more than 10 years.

After his fellowship in the Heidelberg Amyloidosis Center in 2013, Dr. Hansen has received an additional specialty in the treatment of light chain (AL) amyloidosis.

This special consultation session offers diagnosis, risk stratification, and therapy according to current standards.

In addition, each patient examined will be evaluated whether he qualifies for participation in national or international clinical trials - TrialFinder - that involve innovative drugs, some of which are not even available on the market yet.

We also offer medical advice for patients seeking a second opinion.